NANOBODIES Trademark

Trademark Overview

On Thursday, June 10, 2004, a trademark application was filed for NANOBODIES with the United States Patent and Trademark Office. The USPTO has given the NANOBODIES trademark a serial number of 79004985. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, January 19, 2016. This trademark is owned by ABLYNX N.V.. The NANOBODIES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and antibodies for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, cancer,diseases of the central nervous system, infectious diseases; [ veterinary preparations for treating livestock diseases, namely, allergy, immune and inflammatory diseases, metabolic diseases, diseases of the central nervous system, infectious diseases; ] [ diagnostic preparations for medical or veterinary purposes; ] therapeutic preparations and antibodies for medical and veterinary use for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, infectious diseases [ ; diagnostic biological cultures for clinical medical and veterinary use; insecticides ]

Laboratory technician, chemist, engineering and biotechnology services; scientific research and laboratory research in the fields of medical, bacteriological and biotechnical fields; biotechnical research technical consultation and research in the field of biotechnological research; [ industrial property consultancy; ] research with respect to issues of industrial property protection in relation to the biotechnical field
nanobodies

General Information

Serial Number79004985
Word MarkNANOBODIES
Filing DateThursday, June 10, 2004
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, January 19, 2016
Registration Number3032488
Registration DateTuesday, December 20, 2005
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations and antibodies for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, cancer,diseases of the central nervous system, infectious diseases; [ veterinary preparations for treating livestock diseases, namely, allergy, immune and inflammatory diseases, metabolic diseases, diseases of the central nervous system, infectious diseases; ] [ diagnostic preparations for medical or veterinary purposes; ] therapeutic preparations and antibodies for medical and veterinary use for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, infectious diseases [ ; diagnostic biological cultures for clinical medical and veterinary use; insecticides ]
Pseudo MarkNA NO BODIES
Goods and ServicesLaboratory technician, chemist, engineering and biotechnology services; scientific research and laboratory research in the fields of medical, bacteriological and biotechnical fields; biotechnical research technical consultation and research in the field of biotechnological research; [ industrial property consultancy; ] research with respect to issues of industrial property protection in relation to the biotechnical field

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 8, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 8, 2004
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameABLYNX
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameABLYNX N.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameABLYNX N.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Friday, April 12, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, October 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 19, 2017PARTIAL INVALIDATION PROCESSED BY THE IB
Monday, November 21, 2016GENERIC MADRID TRANSACTION SENT TO IB
Monday, November 21, 2016GENERIC MADRID TRANSACTION CREATED
Thursday, November 17, 2016INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Monday, September 19, 2016PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sunday, January 31, 2016NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 19, 2016NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, January 19, 2016SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Tuesday, January 19, 2016REGISTERED-SEC.71 ACCEPTED
Monday, December 7, 2015REGISTERED-SEC.71 FILED
Tuesday, January 19, 2016REGISTERED - SEC. 15 ACKNOWLEDGED
Monday, December 7, 2015REGISTERED - SEC. 15 AFFIDAVIT FILED
Monday, December 7, 2015REGISTERED-SEC.71 FILED
Friday, January 15, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 7, 2015TEAS SECTION 71 RECEIVED
Monday, December 7, 2015TEAS SECTION 15 RECEIVED
Friday, June 26, 2015PARTIAL INVALIDATION PROCESSED BY THE IB
Saturday, February 28, 2015GENERIC MADRID TRANSACTION SENT TO IB
Saturday, February 28, 2015GENERIC MADRID TRANSACTION CREATED
Tuesday, February 17, 2015IRREGULARITY ON INVALIDATION RECEIVED FROM IB
Thursday, June 26, 2014INTERNATIONAL REGISTRATION RENEWED
Monday, June 9, 2014PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 28, 2014NEW REPRESENTATIVE AT IB RECEIVED
Saturday, October 5, 2013PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, February 5, 2013NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
Tuesday, February 5, 2013REGISTERED-SEC.71 ACCEPTED
Thursday, January 24, 2013TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, August 7, 2012POST REGISTRATION ACTION MAILED - SEC.71
Friday, August 3, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 19, 2012TEAS SECTION 71 RECEIVED
Friday, December 10, 2010CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, September 28, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 23, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 23, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 5, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 14, 2006FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 14, 2006FINAL DISPOSITION PROCESSED
Thursday, August 3, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 20, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2005PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2005NOTICE OF PUBLICATION
Tuesday, August 16, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 12, 2005ASSIGNED TO LIE
Thursday, August 11, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 22, 2005AMENDMENT FROM APPLICANT ENTERED
Friday, July 15, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 15, 2005PAPER RECEIVED
Thursday, March 3, 2005REFUSAL PROCESSED BY IB
Monday, January 24, 2005NON-FINAL ACTION MAILED
Thursday, January 13, 2005NON-FINAL ACTION WRITTEN
Monday, January 10, 2005ASSIGNED TO EXAMINER
Friday, October 8, 2004NEW APPLICATION ENTERED
Thursday, October 7, 2004SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

nanobodies diseases research veterinary preparations medical nervous infectious central biotechnical system